FBXO32 and Atrophy: IGF-I has been shown to suppress protein degradation in myotubes induced by dexamethasone by suppressing expression of two muscle-specific ubiquitin ligases (E3s), atrogin-1 and MURF1, which are closely associated with muscle atrophy (Sacheck et al, 2004).